Quarterly Earnings

As MarketAxess preps its Q4 results, investors weigh a mixed 2025. Will its strategic shifts in a volatile fixed-income market deliver on growth promises?

As 8x8 prepares its Q3 FY2026 report, investors are watching to see if its big bet on an integrated AI and CX platform can deliver growth.

Preliminary results beat estimates, but the real story is the pending Kito Crosby acquisition set to double the company's size and reshape its future.

The CEA giant is showcasing profit-driving proprietary tech at Vancouver's Grow Up Expo, signaling a major play for commercial growers in a tough market.

As a 31-year purchasing veteran retires, Grocery Outlet merges key departments under new leadership, a strategic pivot to boost efficiency and profits.

The asset manager closed 2025 with massive assets, but significant Q4 client withdrawals raise questions about strategy ahead of its earnings call.

Vericel posts strong 2025 results driven by its MACI cartilage therapy. The biotech leader is now investing in a new facility and a clinical trial for ankle repair.

Amid market pressures, VirTra showcases its advanced training simulators at SHOT Show, betting on immersive tech to redefine law enforcement training.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

The high-power laser maker exceeded its Q4 guidance, driven by booming demand in aerospace and defense. Here's what it means for its 2026 outlook.

With Vans in a slump and The North Face soaring, VF Corp's new leadership will detail its strategic vision at a key conference watched by Wall Street.

The media giant posts strong Q3 results, unveiling its 'GTPL Infinity' platform to counter competition and capture India's booming digital market.

Medallion Bank promotes from within, elevating key execs to steer its strategy in the specialized RV, boat, and home improvement lending markets.

Sonos adds leaders from Meta, e.l.f. Beauty, and Pandora to its board, signaling a strategic push into AI, platform growth, and financial discipline.

Investors and HR leaders watch as Unum prepares to release its Q4 results and 2026 strategy in a rapidly evolving workplace benefits landscape.

Avalon GloboCare regains Nasdaq compliance, but its future is being reshaped by a bold AI launch and a transformative merger that questions its identity.

Progyny signals better-than-expected 2025 results on robust member engagement, sparking analyst upgrades and sending its stock soaring ahead of a key conference.

As McGraw Hill execs prep for a key investor conference, all eyes are on their digital-first strategy and how they'll navigate the AI-driven EdTech boom.

The wellness firm secured a cash infusion by repricing options, a move that provides vital funds for its Zola brand but raises questions about dilution.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.